Ackman’s Pershing Square cuts losses by selling entire stake in Valeant
March 13, 2017 at 20:14 PM EDT
Bill Ackman just ended his worst investment, selling his hedge fund’s 8 percent stake in debt-laden Valeant Pharmaceuticals International Inc. and taking a $4 billion loss.